Trial Profile
Efficacy of switching from Bevacizumab to Ranibizumab in patients with diabetic macular edema
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2017
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary) ; Bevacizumab
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 24 Nov 2017 New trial record